Such decrease suggests that FGFR-2 down-modulation may be a critical step in thyroid cancer progression, and it can be assumed that FGFR-2 alteration may be an early event in the development of thyroid neoplasia. The gene discussed is FGFR2; the disease is thyroid gland carcinoma.